The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | D | Dermatologicals | |
| 2 | D10 | Anti-acne preparations | |
| 3 | D10A | Anti-acne preparations for topical use | |
| 4 | D10AD | Retinoids for topical use in acne | |
| 5 | D10AD01 | Tretinoin |
| Active Ingredient | Description | |
|---|---|---|
| Tretinoin |
Tretinoin decreases cohesiveness of follicular epithelial cells resulting in decreased microcomedone formation. Additionally, tretinoin stimulates mitotic activity and increased turnover of follicular epithelial cells, causing extrusion of the comedones. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| RETIN-A Cream / Gel | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| STIEVA-A Cream | Health Products and Food Branch (CA) | MPI, CA: SPM |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
